ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 21 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -75.0% | 500 | -75.0% | 0.00% | – |
| Q4 2016 | $12,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $15,000 | -11.8% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $17,000 | +30.8% | 2,000 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | -23.5% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $17,000 | +240.0% | 2,000 | +100.0% | 0.00% | – |
| Q3 2015 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | +100.0% | 1,000 | +171.0% | 0.00% | – |
| Q3 2014 | $3,000 | – | 369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 801,242 | $3,876,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 624,000 | $3,039,000 | 0.18% |
| Rossmore Private Capital | 15,061 | $73,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 3,150 | $15,000 | 0.01% |
| Squarepoint Ops LLC | 14,500 | $71,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
| Close Asset Management Ltd | 2,000 | $10,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,900 | $82,000 | 0.00% |
| SIMPLEX TRADING, LLC | 547 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 861 | $4,000 | 0.00% |